Annadata R, Sessler D I, Tayefeh F, Kurz A, Dechert M
Department of Anesthesia, University of California, San Francisco, USA.
Anesthesiology. 1995 Dec;83(6):1205-11. doi: 10.1097/00000542-199512000-00011.
Shivering is rare during general anesthesia. This observation suggests that anesthetics profoundly impair shivering. However, the effects of surgical doses of volatile anesthetics on control of shivering have yet to be evaluated. Furthermore, the effects of desflurane on sweating and thermoregulatory vasoconstriction remain unknown. Accordingly, the authors determined the concentration-dependent effects of desflurane on sweating, vasoconstriction, and shivering.
Nine volunteers each were studied on three randomly ordered days: (1) control (no anesthesia); (2) a target end-tidal desflurane concentration of 0.5 minimum alveolar concentration (MAC; 3.5%); and (3) a target concentration of 0.8 MAC (5.6%). Each day, volunteers were warmed until sweating was induced and subsequently cooled until peripheral vasoconstriction and shivering was observed. Changes in skin temperature were arithmetically compensated using the established linear cutaneous contributions to control of each response. From the calculated thresholds (core temperatures triggering responses at a designated skin temperature of 34 degrees C), the concentration-response relationship was determined.
Desflurane significantly and linearly increased the sweating threshold from 37.1 +/- 0.3 degrees C on the control day (mean +/- SD), to 37.6 +/- 0.4 degrees C at 0.5 MAC, and to 38.1 +/- 0.3 degrees C at 0.8 MAC. Desflurane significantly, but nonlinearly, reduced the vasoconstriction and shivering thresholds. The sweating-to-vasoconstriction (interthreshold) range thus increased from 0.5 +/- 0.3 degrees C to 2.3 +/- 0.7 degrees C at 0.5 MAC and further to 4.6 +/- 2.0 degrees C at 0.8 MAC. The vasoconstriction-to-shivering range (difference between the respective thresholds) remained between 1.1 and 1.5 degrees C on the three study days.
The observed linear increase in the sweating threshold was similar in pattern and magnitude to that produced by most general anesthetics. The approximately 3 degrees C reduction in the vasoconstriction threshold by 0.8 MAC desflurane was similar to that observed previously during isoflurane and propofol anesthesia. However, the threshold was reduced less than expected at 0.5 MAC, suggesting that the dose-response relationship for vasoconstriction is nonlinear. Shivering was induced without difficulty in this study although the response is rare in surgical patients. It is likely that shivering during general anesthesia is rare because thermoregulatory vasoconstriction usually prevents body temperature from decreasing the required additional 1-1.5 degrees C.
全身麻醉期间寒战很少见。这一观察结果表明麻醉剂会严重损害寒战反应。然而,手术剂量的挥发性麻醉剂对寒战控制的影响尚未得到评估。此外,地氟醚对出汗和体温调节性血管收缩的影响仍不清楚。因此,作者确定了地氟醚对出汗、血管收缩和寒战的浓度依赖性影响。
9名志愿者在3个随机安排的日子里接受研究:(1)对照(无麻醉);(2)目标呼气末地氟醚浓度为0.5最低肺泡浓度(MAC;3.5%);(3)目标浓度为0.8 MAC(5.6%)。每天,先将志愿者加热至出汗,随后冷却至观察到外周血管收缩和寒战。使用既定的线性皮肤贡献来算术补偿皮肤温度变化,以控制每种反应。根据计算出的阈值(在指定皮肤温度34摄氏度时触发反应的核心温度),确定浓度-反应关系。
地氟醚显著且呈线性地提高出汗阈值,从对照日的37.1±0.3摄氏度(均值±标准差),提高到0.5 MAC时的37.6±0.4摄氏度,以及0.8 MAC时的38.1±0.3摄氏度。地氟醚显著但非线性地降低血管收缩和寒战阈值。出汗至血管收缩(阈值间)范围因此从0.5±0.3摄氏度增加到0.5 MAC时的2.3±0.7摄氏度,并在0.8 MAC时进一步增加到4.6±2.0摄氏度。在三个研究日中,血管收缩至寒战范围(各自阈值之间的差值)保持在1.1至1.5摄氏度之间。
观察到的出汗阈值的线性增加在模式和幅度上与大多数全身麻醉剂产生的情况相似。0.8 MAC地氟醚使血管收缩阈值降低约3摄氏度,这与先前在异氟醚和丙泊酚麻醉期间观察到的情况相似。然而,在0.5 MAC时阈值降低幅度小于预期,表明血管收缩的剂量-反应关系是非线性的。尽管在手术患者中寒战反应很少见,但在本研究中很容易诱发寒战。全身麻醉期间寒战可能很少见,因为体温调节性血管收缩通常可防止体温进一步下降所需的1 - 1.5摄氏度。